Thesis — XRC: Retail Tech, Consumer Healthtech & Consumer Goods

Thesis is the world's first nootropics brand that sells personalized brain supplements that provide on demand focus, energy and productivity for motivated people who struggle with brain fog and burnout but don't want to rely on prescription medications unlike Qualia and Alpha brain who offer only one-size-fits-all products with low efficacy. Thesis uses data science to help tailor products to our user's unique biology and daily activities.

Website | Facebook | Instagram

FOUNDERS

Thesis Founders

Dan Freed

Co-Founder and CEO

Grew up in Los Angeles, worked internationally for a decade, studied at INSEAD + Yale. I’m now in New York building Thesis: the world’s only personalized brain supplements (nootropics) company. Nootropics have had a huge impact on my life. They’ve helped me go from a sandwich artist at Subway to cooking in a Michelin three-star restaurant, and from being a high school drop-out to obtaining degrees in world-class universities. We believe that everyone should have access to nootropics so they can realize their full potential.

Adam Greenfeld

Co-Founder and CMO

Grew up in upstate New York, worked in marketing/sales for 12 years. I was part of the team that brought the Nets to Brooklyn and helped real estate startup, PivotDesk double national sales in less than a year. Now, I am the co-founder of Thesis, the world’s first personalized nootropics company. I’ve traveled the world, studied dozens of disciplines and still had no idea how well my brain could work until I found nootropics. Outside of work, I am an avid crossfitter, surfer, coffee drinker, and biohacker.